Literature DB >> 8560772

Herpes simplex virus recombination vectors designed to allow insertion of modified promoters into transcriptionally "neutral" segments of the viral genome.

J Singh1, E K Wagner.   

Abstract

The use of recombinant viruses has been essential in investigation of the biology of herpes simplex virus (HSV). In this communication we describe a number of viral recombination vectors that we have generated for use in promoter structure/function analysis within the context of the HSV-1 genome. We have utilized two regions of the HSV genome that contain genes nonessential for replication in cultured cells--the glycoprotein C (gC or UL44) locus in the UL of the genome and the area encompassing the promoter and 5' portion of the latency associated transcript (LAT) within the RL factual influence on promoters due to the site of insertion. Two different kinetic promoters were analyzed, those controlling expression of the gamma UL 38 and the beta dUTPase genes, in both loci. All constructs tested displayed reporter gene mRNA expression with expected kinetics, and we conclude that there are no neighboring cryptic promoter elements that could interfere with expression studies using the vectors described.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560772     DOI: 10.1007/bf01702593

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  48 in total

1.  The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons.

Authors:  K A Lillycrop; C L Dent; S C Wheatley; M N Beech; N N Ninkina; J N Wood; D S Latchman
Journal:  Neuron       Date:  1991-09       Impact factor: 17.173

2.  A single regulatory region modulates both cis activation and trans activation of the herpes simplex virus VP5 promoter in transient-expression assays in vivo.

Authors:  E D Blair; E K Wagner
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

Review 3.  Transcriptional selectivity of viral genes in mammalian cells.

Authors:  S McKnight; R Tjian
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

4.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

Authors:  M E Campbell; J W Palfreyman; C M Preston
Journal:  J Mol Biol       Date:  1984-11-25       Impact factor: 5.469

5.  gamma 2-Thymidine kinase chimeras are identically transcribed but regulated a gamma 2 genes in herpes simplex virus genomes and as beta genes in cell genomes.

Authors:  S Silver; B Roizman
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

6.  Glycoprotein C-dependent attachment of herpes simplex virus to susceptible cells leading to productive infection.

Authors:  G Campadelli-Fiume; D Stirpe; A Boscaro; E Avitabile; L Foá-Tomasi; D Barker; B Roizman
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

7.  Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter.

Authors:  C J Huang; S A Goodart; M K Rice; J F Guzowski; E K Wagner
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Molecular characterization of naturally occurring glycoprotein C-negative herpes simplex virus type 1.

Authors:  Y Toh; S Tanaka; Y Liu; Y Hidaka; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  A bi-functional reporter plasmid for the simultaneous transient expression assay of two herpes simplex virus promoters.

Authors:  W M Flanagan; E K Wagner
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

10.  Virus-induced modification of the host cell is required for expression of the bacterial chloramphenicol acetyltransferase gene controlled by a late herpes simplex virus promoter (VP5).

Authors:  R H Costa; K G Draper; G Devi-Rao; R L Thompson; E K Wagner
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

View more
  8 in total

1.  The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells.

Authors:  P T Lieu; E K Wagner
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2.

Authors:  R J Roller; B C Herold
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Purification and characterization of a cellular protein that binds to the downstream activation sequence of the strict late UL38 promoter of herpes simplex virus type 1.

Authors:  M D Petroski; E K Wagner
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Herpesvirus entry mediator HVEM mediates cell-cell spread in BHK(TK-) cell clones.

Authors:  R J Roller; D Rauch
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Bile salts: natural detergents for the prevention of sexually transmitted diseases.

Authors:  B C Herold; R Kirkpatrick; D Marcellino; A Travelstead; V Pilipenko; H Krasa; J Bremer; L J Dong; M D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens.

Authors:  B C Herold; A Siston; J Bremer; R Kirkpatrick; G Wilbanks; P Fugedi; C Peto; M Cooper
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

7.  The exchange of cognate TATA boxes results in a corresponding change in the strength of two HSV-1 early promoters.

Authors:  P T Lieu; N T Pande; M K Rice; E K Wagner
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

8.  A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system.

Authors:  Zane Zeier; J Santiago Aguilar; Cecilia M Lopez; G B Devi-Rao; Zachary L Watson; Henry V Baker; Edward K Wagner; David C Bloom
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.